Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine.
作者信息
Engeland Christine E
机构信息
Faculty of Health/School of Medicine, Institute of Virology and Microbiology - Experimental Virology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, Witten, Germany.
Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Department of Medical Oncology, Heidelberg, Germany.
出版信息
Mol Ther Methods Clin Dev. 2022 Sep 24;27:90-92. doi: 10.1016/j.omtm.2022.09.003. eCollection 2022 Dec 8.
Abstract
摘要
相似文献
1
Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine.安全性研究支持免疫治疗性溶瘤麻疹疫苗的临床开发。
Mol Ther Methods Clin Dev. 2022 Sep 24;27:90-92. doi: 10.1016/j.omtm.2022.09.003. eCollection 2022 Dec 8.
2
Mechanisms of measles virus oncolytic immunotherapy.麻疹病毒溶瘤免疫疗法的作用机制。
Cytokine Growth Factor Rev. 2020 Dec;56:28-38. doi: 10.1016/j.cytogfr.2020.07.009. Epub 2020 Jul 3.
3
[Synergistic Effect of NF-κB Signaling Pathway Inhibitor and Oncolytic
Measles Virus Vaccine Strain against Lung Cancer and Underlying Mechanisms].[NF-κB信号通路抑制剂与溶瘤麻疹病毒疫苗株对肺癌的协同作用及潜在机制]
Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):245-253. doi: 10.3779/j.issn.1009-3419.2021.102.14. Epub 2021 Mar 29.
4
Measles to the Rescue: A Review of Oncolytic Measles Virus.麻疹来救援：溶瘤性麻疹病毒综述
Viruses. 2016 Oct 22;8(10):294. doi: 10.3390/v8100294.
5
Attenuated oncolytic measles virus strains as cancer therapeutics.减毒溶瘤麻疹病毒株作为癌症治疗剂。
Curr Pharm Biotechnol. 2012 Jul;13(9):1732-41. doi: 10.2174/138920112800958896.
6
Oncolytic measles virus strains as novel anticancer agents.溶瘤麻疹病毒株作为新型抗癌药物。
Expert Opin Biol Ther. 2013 Apr;13(4):483-502. doi: 10.1517/14712598.2013.749851. Epub 2013 Jan 6.
7
Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice.安全性研究：向麻疹免疫、人CD46转基因、IFNαR基因敲除小鼠脑室内注射改良的溶瘤麻疹病毒
Hum Gene Ther Clin Dev. 2016 Dec;27(4):145-151. doi: 10.1089/humc.2016.062. Epub 2016 Sep 7.
8
MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.MeV-Stealth：一种对麻疹免疫的人血清中和作用具有抗性的CD46特异性溶瘤麻疹病毒。
PLoS Pathog. 2021 Feb 3;17(2):e1009283. doi: 10.1371/journal.ppat.1009283. eCollection 2021 Feb.
9
Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations.对连续传代的麻疹病毒进行测序证实了其基因组的稳定性，并揭示了一致突变的非随机分布。
J Gen Virol. 2020 Apr;101(4):399-409. doi: 10.1099/jgv.0.001395. Epub 2020 Feb 13.
10
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.利用携带酵母胞嘧啶脱氨酶和尿嘧啶磷酸核糖转移酶的溶瘤麻疹疫苗病毒增强卵巢癌的杀伤作用。
Gynecol Oncol. 2013 Aug;130(2):362-8. doi: 10.1016/j.ygyno.2013.05.004. Epub 2013 May 12.
引用本文的文献
1
Anticancer Activity of Measles-Mumps-Rubella MMR Vaccine Viruses against Glioblastoma.麻疹-腮腺炎-风疹（MMR）疫苗病毒对胶质母细胞瘤的抗癌活性
Cancers (Basel). 2023 Aug 28;15(17):4304. doi: 10.3390/cancers15174304.
本文引用的文献
1
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an immunostimulatory bacterial transgene.MV-s-NAP的临床前安全性评估，MV-s-NAP是一种携带免疫刺激细菌转基因的新型溶瘤麻疹病毒株。
Mol Ther Methods Clin Dev. 2022 Jul 31;26:532-546. doi: 10.1016/j.omtm.2022.07.014. eCollection 2022 Sep 8.
2
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory.编码程序性死亡蛋白1（PD-1）和程序性死亡配体1（PD-L1）检查点阻断抗体的溶瘤麻疹疫苗，以增强肿瘤特异性T细胞记忆。
Mol Ther Oncolytics. 2021 Nov 29;24:43-58. doi: 10.1016/j.omto.2021.11.020. eCollection 2022 Mar 17.
3
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy.免疫刺激性细菌抗原武装溶瘤麻疹病毒治疗显著增强了抗 PD-1 检查点治疗的效力。
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI141614.
4
Measles Virus as an Oncolytic Immunotherapy.麻疹病毒作为一种溶瘤免疫疗法。
Cancers (Basel). 2021 Feb 1;13(3):544. doi: 10.3390/cancers13030544.
5
Mechanisms of measles virus oncolytic immunotherapy.麻疹病毒溶瘤免疫疗法的作用机制。
Cytokine Growth Factor Rev. 2020 Dec;56:28-38. doi: 10.1016/j.cytogfr.2020.07.009. Epub 2020 Jul 3.
6
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma.溶瘤麻疹病毒疗法增强多发性骨髓瘤患者的肿瘤抗原特异性 T 细胞反应。
Leukemia. 2020 Dec;34(12):3310-3322. doi: 10.1038/s41375-020-0828-7. Epub 2020 Apr 23.
7
Immunomodulation in Oncolytic Measles Virotherapy.溶瘤麻疹病毒疗法中的免疫调节
Methods Mol Biol. 2020;2058:111-126. doi: 10.1007/978-1-4939-9794-7_7.
8
Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy.抗体中和的呼肠孤病毒在溶瘤病毒治疗中有效。
Cancer Immunol Res. 2018 Oct;6(10):1161-1173. doi: 10.1158/2326-6066.CIR-18-0309. Epub 2018 Sep 12.
9
Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors.溶瘤病毒载体靶向表达双特异性 T 细胞衔接子增强实体瘤治疗效果。
Clin Cancer Res. 2018 May 1;24(9):2128-2137. doi: 10.1158/1078-0432.CCR-17-2651. Epub 2018 Feb 6.
10
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.抗病毒免疫的抗肿瘤益处：溶瘤病毒治疗的一个被低估的方面。
Trends Immunol. 2018 Mar;39(3):209-221. doi: 10.1016/j.it.2017.11.006. Epub 2017 Dec 20.
Zotero 插件